June 5, 2017 | Israeli startup Belkin Laser, a portfolio company of Israel’s RAD Biomed accelerator, has secured $5 million in funding from Zicom Holdings, Rimonci Capital and the European Union (grant). The capital raised adds to the $1.5 million previously raised by the company. Belkin Laser develops a laser device for glaucoma patients who will receive short, efficient treatments, instead of the eye drops used today. Belkin Laser was founded in 2013 under a license agreement from Israel’s Sheba Medical Center and Tel Aviv University. Its product is based on Prof. Michael Belkin’s invention. [Photo: TobiasD]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments